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ABSTRACT Individuals expressing hemoglobin C (b6 Glu/Lys) present red blood cells (RBC) with intraerythrocytic crystals
that form when hemoglobin (Hb) is oxygenated. Our earlier in vitro liquid-liquid (L-L) phase separation studies demonstrated that
liganded HbC exhibits a stronger net intermolecular attraction with a longer range than liganded HbS or HbA, and that L-L phase
separation preceded and enhanced crystallization. We now present evidence for the role of phase separation in HbC
crystallization in the RBC, and the role of the RBC membrane as a nucleation center. RBC obtained from both human
homozygous HbC patients and transgenic mice expressing only human HbC were studied by bright-ﬁeld and differential
interference contrast video-enhanced microscopy. RBC were exposed to hypertonic NaCl solution (1.5–3%) to induce
crystallization within an appropriate experimental time frame. L-L phase separation occurred inside the RBC, which in turn
enhanced the formation of intraerythrocytic crystals. RBC L-L phase separation and crystallization comply with the thermo-
dynamic and kinetics laws established through in vitro studies of phase transformations. This is the ﬁrst report, to the best of our
knowledge, to capture a temporal view of intraerythrocytic HbC phase separation, crystal formation, and dissolution.
INTRODUCTION
Individuals expressing hemoglobin C (b6 Glu/Lys) (HbC)
manifest red blood cells (RBC) with intraerythrocytic Hb
crystals (1) that form when Hb is in the oxygenated state (2).
The formation of these crystals initiates the pathophysiology
of homozygous CC disease and contributes to the signiﬁ-
cantly more severe heterozygous SC disease. (For a review of
the clinical manifestations, see Nagel and Steinberg (3)).
Selective pressure for the bC-globin gene exists because of its
protective effects against malaria (4). RBC membrane alter-
ations are shown to underlie the protective effects of HbC to
malaria (e.g., Tokumasu et al. (5) and Fairhurst et al. (6)).
We have directed our efforts toward understanding the
molecular mechanisms involved in the high propensity for
liganded HbC to form crystals (7–12). Previous investiga-
tions, carried out in vitro in the presence of concentrated
phosphate buffer, revealed that HbC crystals grow by the
addition of single Hb molecules to special growth sites
(kinks) on the crystal surface. These sites are located along
the edges of unﬁnished crystalline layers, which are gener-
ated by dislocations or two-dimensional nucleation on the
crystal surface (11). The solubility of HbC crystals is very
sensitive to temperature and decreases as temperature is
raised (8). In vitro, 1), HbC crystals nucleate following
classical mechanisms of homogeneous nucleation, whereby
local concentration ﬂuctuations result in the crystalline nu-
cleus at a random location and at a random moment (8), and
2), liganded HbC shows a signiﬁcant propensity for revers-
ible liquid-liquid (L-L) phase separation, whereby the re-
sulting phase diagrams provide evidence that liganded HbC
exhibits a stronger net intermolecular attraction with a longer
range than liganded HbS and HbA (13).
Bright-ﬁeld and differential interference contrast (DIC)
microscopy showed that although some precrystalline ag-
gregates of HbC form inside the dense Hb protein droplets,
most crystals grow from the edge of the droplets or aggre-
gates (13). This observation is not surprising since edge ef-
fects on protein crystal growth have been previously reported
(14–17). On the other hand, in some systems the crystal
readily forms inside the dense phase droplets (18). Dense
liquid droplets were also found to serve as preferential lo-
cations for the nucleation and growth of polymers of sickle
cell Hb, another Hb mutant (b6 Glu/Val) (19). The control
parameter that determines whether crystals nucleate inside of
dense liquid droplets appears to be dependent on viscosity
(20): in highly viscous environments, molecular motion is
hampered and the molecules cannot arrange themselves into
ordered crystalline nuclei. Yet, it was found that protein
solutions increase their concentration as they approach an
interface (21), and rapid diffusion of molecules at L-L
interfaces accelerates nucleation (22). Thus, we explained the
lack of HbC crystal formation inside the dense phase droplets
by the high internal viscosity (13). The higher surface con-
centration and the higher mobility at the droplet surface are
the main factors underlying the enhancement of nucleation in
the presence of dense liquid droplets. In studies of human
homozygous HbC RBC (23), precrystalline aggregates have
been observed in higher-viscosity RBC compared to normal
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HbA RBC, and a temperature-dependent HbC crystallization
similar to our in vitro ﬁndings (8,9,13,24) has been reported.
In the study presented here, three questions are addressed:
1. Does L-L phase separation occur in HbC red blood cells?
This question is related to the broader issue of the
cytosolic phase state of various cells. There has been
speculation that the free solution in the cytosol may be
heterogeneous and contain several liquid phases in dy-
namic equilibrium (25).
2. Is L-L phase separation related to the formation of
crystals inside the RBC cytosol? This question is related
to the mechanism of formation of ordered phases in
living organisms, some of which have physiological
functional signiﬁcance (26–28).
3. Is crystal formation inside the RBC cytosol subject to
thermodynamic and kinetic laws that govern phase
transformations according to Gibbs and Volmer (29,30)?
For this investigation, RBC from human CC individuals
and transgenic HbC full knockout mouse (HbC full KO, a
mouse model that expresses solely humanHbC and nomouse
globins (31)) were studied. The transgenic mouse HbC full
KO RBC is a good model for these studies because it was
recently demonstrated that human HbC (and human HbS and
HbE) bind to the mouse RBC membrane with greater afﬁnity
than mouse globins (32), paralleling the higher afﬁnity of
these mutant Hbs to the human RBC membrane (33,34). The
transgenic HbCmouse RBC is similar in phenotype to human
CC RBC (31) and, moreover, provides unlimited and ready
access to CC RBC. Evidence is presented to answer the
questions enumerated above and demonstrate a role for the
RBC membrane as a nucleation center in intraerythrocytic
HbC crystals. This is the ﬁrst report, to the best of our
knowledge, to capture the in situ temporal stages of intra-
erythrocytic HbC crystal formation and dissolution.
MATERIALS AND METHODS
Human venous blood
Human venous blood was obtained from human donors homozygous for
HbC, with informed consent, using a protocol based on the National of
Institutes of Health guidelines and approved by the Committee on Clinical
Investigations/Institutional Review Board of the Albert Einstein College of
Medicine. Blood was collected in heparinized vacutainer tubes. Human
RBC, washed three times in isotonic saline (human, 0.9 g% (290 mosm))
were placed on a continuous Larex-Percoll density gradient. The dense
fraction containing predominantly crystal-containing cells (35) was har-
vested. These cells were incubated at temperatures of;37C and viewed by
light microscopy.
HbC transgenic mouse RBC
Under a protocol approved by the AECOM Institute for Animal Studies,
blood was drawn from the tail vein of an anesthetized mouse expressing
solely human HbC (31) into heparinized isotonic mouse saline (mouse
1.05g% (330 mosm)). Since the transgenic mice were bred on a C57BL/6
(C57) background, RBC from C57 mice were used as controls. Mouse RBC
were separated from plasma and washed three times in their respective iso-
tonic saline. To induce maximal crystal formation within an acceptable ex-
perimental time frame, the washed RBC were incubated at 37C in 3% NaCl
(1:1 RBC:3% NaCl) from 2 h to up to 4 h. To ensure RBC separation in the
microscope ﬁeld, the incubated RBC suspensionwas further diluted (one part
incubated RBC : seven parts 3% NaCl), and from this a 3-mL aliquot was
placed on a glass slide and viewed by light microscopy and video-enhanced
DIC microscopy. Then ;10 mL isotonic saline (mouse) were added to the
coverslip edge and crystal dissolution was recorded by video-enhanced DIC
microscopy as described in Chen et al. (13).
To assess the sensitivity of crystallization to temperature and composition
variations, a chamber was created by gluing a coverslip, a spacer, and two
ports to the glass slide. The two ports allowed exchange of the solution in
which the RBC were incubated. A brass box with two ports connected to a
temperature-controlling water circulator was glued to the slide. Temperature
was measured with an HH 506R thermocouple thermometer (Omega
Engineering, Stamford, CT) with 0.1C accuracy and input to a computer
using a serial port. The cells were attached to the bottom of the slide using the
following procedure: The chamber was ﬁlled with poly-L-lysine solution for
20 min and then washed with deionized water. The chamber was then ﬁlled
with a solution of RBC and kept stationary for 20 min to allow the cells to
adhere to the slide. Unattached cells were carefully washed away by passing
NaCl solution through the chamber. The initial temperature for the experi-
ments was set to 37C using a water bath. The setup was mounted on a Leica
DMR straight microscope and viewed using DIC optics: a 633HCXAPOL
U-V-I water immersion objective, and a 0.90 S1 achromatic condenser (see
Weber et al. (49)). Pictures were taken with a Hitachi VCC-151 color video




To test whether L-L phase separation occurs in the cytosol
of RBC, two sources of HbC containing RBC were studied:
1), the RBC dense fraction (separated on a Percoll-Larex
gradient) obtained from human CC patients; and 2), RBC
from transgenic mice expressing exclusively human HbC
(31). Although the transgenic mouse RBC consists of HbC
encased in a mouse membrane with differing proportions of
cytosolic components, the transgenic HbC RBC phenotype is
very similar to that seen in human CC RBC with increased
RBC density, increased MCHC, and increased K:Cl co-
transport (31). Therefore, Fabry et al. (31) concluded that
HbC is responsible for the abnormal RBC phenotype. Hence,
the transgenic HbC mouse RBC serves as a good model for
studying HbC crystallization and dissolution in RBC.
To accelerate RBC HbC nucleation and crystal growth
within an appropriate experimental time frame, cells were
incubated using a hypertonic NaCl solution and studied for
indications of L-L phase separation. Signiﬁcant differences
were observed between the RBC containing HbC and normal
(C57) mice RBC cells exposed to the hypertonic NaCl
solution. The majority of the cells with human HbC exhibited
regions of different color density by 150 min incubation
(Fig. 1 A). The number of cells exhibiting dense edge effects
increased exponentially over time (Fig. 2). In some cells,
regions of intense coloration appeared along the cell edge
(Fig. 1 B). In other cells, several round-shaped regions of
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,1 mm in diameter were randomly scattered throughout the
cytosolic intracellular space after more prolonged incubation
(4 h) (Fig. 1 C). In both cases, the edges between these dense
regions and the ‘‘normal’’ (less dense) cytosol were sharp.
We attribute the high color intensity to higher concentrations
of Hb in the dark regions. The sharp edges suggest the
presence of a phase boundary, and the round shape suggests
that the Hb rich phase is liquid (i.e., that L-L phase separation
has occurred). If this phase forms in the vicinity of the cell
membrane, it apparently wets it, and this yields the pattern
seen in Fig. 1 B. If the Hb-rich phase forms away from the cell
membrane, it forms drops of solution whose round shape, as
shown in Fig. 1 C, is determined by the minimization of the
surface free energy. It is established that L-L phase separation
usually appears as liquid protein droplets characterized by a
high protein density. (Details of the principles of L-L phase
separation with regard to Hb solutions are discussed at length
in Chen et al. (13)).
L-L phase separation is known to be sensitive to solution
composition (13). One of the factors known to enhance L-L
separation is higher concentrations of electrolytes (36). To
further conﬁrm L-L phase separation in the RBC cytosol,
cells were exposed to a lower (2.2%) concentration of NaCl.
It was observed that the regions of higher Hb concentration,
both along the cell edges, as in Fig. 1 B, and away from them,
as in Fig. 1C, disappear. Reversibility is characteristic of L-L
phase separation. Hence, these observations strongly suggest
that the formation of Hb-rich borders along the cell mem-
brane and of the Hb-rich droplets inside the RBC is L-L phase
separation in the RBC cytosol.
In contrast to the transgenic mice HbC RBC, the fraction of
RBC from normal C57Bl control mice exhibiting inhomo-
geneous Hb concentration is signiﬁcantly lower and reaches
;5% only after 3 h of incubation. This trend is explained by
the higher propensity of HbC in vitro to form a dense liquid
phase compared to other Hb variants (13). The mechanistic
basis for the speciﬁcity of HbC toward this phase transition,
as well as its high propensity to nucleate and form crystals, is
due to a stronger net intermolecular attraction with a longer
range than other Hb variants (13).
Crystal formation
After L-L coexistence was observed in some HbC RBC from
the transgenic HbC mouse, further incubation (for ;1 h) led
to the formation of intraerythrocytic crystals. Remarkably,
crystals formed predominantly in cells displaying L-L phase
separation. Examples of the observed crystals are seen in
Figs. 1 D, 3, and 5–7. All intraerythrocytic crystals were
faceted and some were positioned in such a way that the
tetragonal dipyramid shape that is typical of HbC crystals (as
observed when grown in vitro in concentrated phosphate, and
in vivo (2,10,37)) was detectable despite the imaging inter-
ference of the cell membrane.
To probe the dissolution behavior of the intraerythrocytic
crystals observed in this study, we used two approaches: 1),
dilution of the solution around the RBC by the addition of
isotonic mouse saline to the coverslip edge; and 2), lowering
FIGURE 1 Human CC (HbC homozygous) dense RBC exhibiting crys-
tals, heterogeneous Hb densities, and edge effects. Washed human CC RBC
were placed and separated according to density on a Percoll-Larex density
gradient. The densest fraction was incubated at varying temperatures. At
41C for 2 h, maximum crystals (D) and precrystalline formations appeared
(A–C).
FIGURE 2 Percent RBC from CC transgenic mice expressing solely
human HbC that exhibit dense Hb edge effects as a function of incubation
time. Packed RBC were incubated using 3% NaCl (1:1 packed RBC:3%
NaCl yielded 1.5% NaCl as the starting concentration) at 37C. Each point
represents the average of three separate counts. See Materials and Methods
for details.
HbC Crystal Growth in Erythrocytes 4027
Biophysical Journal 95(8) 4025–4033
temperature. The intraerythrocytic crystals dissolved in
minutes after addition of isotonic saline. Crystal dissolution
started away from the crystal face closest to the RBC edge. Of
note, the smallest remaining part of the melting crystal re-
mained tethered to the RBC edge (presumably the mem-
brane) until loss of the characteristic sharp edges and ﬁnal
dissolution of the crystal occurred (Fig. 3 and the Supple-
mentary Information, Movie S1 and Movie S2, Data S1). In
many cases, at a certain point, a dense liquid droplet emerged
from the dissolving crystal. This structure was not tethered to
the membrane and exhibited Brownian-like motion until ﬁnal
dissolution (see Movie S1 and Movie S2, Data S1).
Observations of Brownian motion of these rounded forms
and its fast dissolution are consistent with the properties of
dense liquid droplets and L-L phase separation. Therefore,
we conclude that L-L phase separation precedes HbC crys-
tallization in the RBC. Furthermore, this emerged dense
liquid droplet could have served as the site of nucleation and
growth for that crystal.
The dissolution time of the crystals correlates with crystal
size, with larger crystals taking longer to dissolve (Fig. 4). A
polynomial analysis of the dissolution time with crystal size
(area) is used because we are monitoring the cross-sectional
area of the crystal in the image plane, and this area should
decrease as the product of the rate of retraction on each side.
Thus, with a constant dissolution rate, the rate of retraction of
each side is linearly dependent on time, and the area de-
creases as a quadratic dependence. The only assumption
made is that the dissolution has reached a steady state, i.e., the
number of molecules departing from a unit surface area of
the crystal does not change in time. It should be noted that the
argument is purely geometrical and contains no assumptions
as to whether the kinetics of dissolution at the crystal’s sur-
face or diffusion of Hb away from the crystal is the rate-
determining step.
A polynomial ﬁt of the time t dependence of the area
covered by crystals during dissolution reveals a t3 law in all
10 tested cases in Fig. 4. If the rate of dissolution of the
crystal faces is constant, the area should decrease as t2. The
cubic dependence indicates that the rate of dissolution in-
creases as the crystal size decreases. Such dependencies have
been interpreted as evidence for strain in small crystals (38).
The likely source of this strain is the unstructured aggregate
revealed at the end of dissolution. The generality of the strain
suggests that all observed crystals contain such aggregates,
and it is likely that the aggregates are the objects upon which
heterogeneous nucleation of crystallization occurs.
To test whether intraerythrocytic crystal formation is
subject to the laws of thermodynamics that govern all phase
transitions, the sensitivity of crystal formation to temperature
was examined. Crystals were formed by incubating HbC
transgenic mouse RBC in a hypertonic NaCl solution at 37C
(Fig. 5). After crystal formation was detected, using the inlet
and outlet ports of the setup described above, this solution
was completely replaced by 2.2% NaCl. In this solution, the
crystals were stable at 37C. However, as soon as the tem-
perature was lowered to 35C, the crystals completely dis-
solved within ;2 min (Fig. 5). This observation shows that
HbC crystallization in RBC follows the same retrograde
dependence of solubility on temperature (higher solubility at
lower temperature), as seen in vitro (8,24). Regarding the
reproducibility and signiﬁcance of the temperature values,
we have observed hundreds of cells under slightly varying
conditions. The response to temperature of dissolution and
the formation of dense liquid droplets was consistent with all
cells observed. The data shown are representative for all
observations. Of course, depending upon the exact concen-
tration of the NaCl used in the incubating solution, crystal-
lization equilibrium was reached at expected corresponding
different temperatures. Likewise, minor variations in the
NaCl concentration led to anticipated slight changes in the
exact temperatures of the monitored events. The crystalliza-
tion of HbC in RBC occurs in a complex cellular environ-
ment where fractional environmental differences will have an
FIGURE 3 Intraerythrocytic HbC crystal dissolution in-
duced by a change in tonicity over time. Video-enhanced
DIC microscopy images are stills from a video recording
(Movie S1 and Movie S2, Data S1) following crystal
dissolution over time (0.1 s in video time corresponds to
5 s in real time). Crystal formation in transgenic mouse
RBC containing solely human HbC was induced by incu-
bation with 3%NaCl (1:1 packed RBC:3% NaCl) for 3 h.
Crystal dissolution was induced by osmotic change with the
addition of ;10 mL isotonic mouse saline to the coverslip
edge. In the sequence shown, crystal dissolution occurred
within 150 s. See Materials and Methods for complete
details of crystal formation and dissolution.
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impact on crystal growth. This is well known for in vitro
crystallization, and thus serves as another example of how the
observed intraerythrocytic crystal growth exhibits properties
of in vitro crystal growth.
To test the reversibility of crystal formation, the crystals
shown in the ﬁrst (left) panel in Fig. 6 were exposed to 2.5%
NaCl solution. As shown in Fig. 5, the crystals were stable
at 37C. The temperature was then gradually lowered to
35C. Surprisingly, the RBC on the right in the left panel
formed a crystal only after the initial temperature decrease,
at ;36.5C. This observation means that the cytosol with-
out crystals was supersaturated at this temperature, and was
even more supersaturated at the initial 37C. The lack of
crystals in that cell at 37C indicates that nucleation of the
crystal in the RBC cytosol is a process that has to overcome
a barrier. In this respect, this crystal formation is analogous
to all nucleation processes in vitro (39–41). The likely
scenario of crystal nucleation at ;36.5C is that the initial
temperature decrease caused a temperature gradient that
induced solution ﬂow in the RBC cytosol (42,43). Solution
ﬂow, in turn, enhanced crystal nucleation (44,45) and led to
the formation of the crystal seen in the RBC in the right
column of Fig. 6.
As the temperature approached and then remained at 35C,
the crystals in both cells partially dissolved. The HbC re-
leased upon dissolution of the outer crystal layers increased
the HbC concentration in the RBC cytosol to the solubility
level and dissolution stopped. This observation shows that
the solubility at 35C in 2.5% NaCl is lower than in a 2.2%
NaCl solution. Lower solubility at higher electrolyte con-
centration is consistent with earlier in vitro observations (8).
Furthermore, after the temperature in this experiment was
raised to 37C, the crystal grew back. Thus, crystal growth in
the RBC is an entirely reversible process and subject to all
thermodynamic controls that govern phase transformations
of all substances in vitro. The possibility that the dense red
regions or crystals may be Hb amorphous aggregates is ruled
out by this reversibility, the round shape of the dense regions,
and their fast dissolution (Figs. 6 and 7).
To probe the temperature at which the RBC cytosol is in
equilibrium with the crystal, we studied intraerythrocytic
crystals that formed after incubation in 3% NaCl at 37C.
The incubating solution was then completely replaced with
a 2.5% NaCl ﬁnal concentration (see Materials andMethods
section). The temperature was lowered in steps, waiting for
the cessation of dissolution and the establishment of equi-
librium between the crystal and cytosol at each temperature
step. Fig. 7 shows the steps between 35.7C and 30.6C.
The single crystal seen in the RBC dissolved completely at
31.0C (Fig. 7, right column), whereas the last small crys-
tals in the RBC (seen in the left column of Fig. 7) dissolved
only at 30.6C. The difference in the two equilibrium
FIGURE 5 Intraerythrocytic HbC crystal dissolution induced by a change
in temperature. Imaging by temperature-controlled DIC microscopy dem-
onstrated intraerythrocytic crystals formed upon incubation of RBC at T ¼
37C in hypertonic NaCl solution. The incubating solution was replaced by a
2.2% solution. Crystal dissolution started only after T was lowered to 35C.
The accuracy of temperature control is 0.1C (see Materials and Methods).
The crystals were completely dissolved within ;2 min.
FIGURE 4 Intraerythrocytic HbC crystal disso-
lution as a function of time. The area of the
intraerythrocytic crystal (and during dissolution)
was measured from photos taken over time. Crys-
tals 1 and 2, 3 and 4, 5 and 6, and 7–10, respec-
tively, belonged to the same cells (total cells with
respect to these crystals: four). All photos were
taken at the same magniﬁcation. See Fig. 3 caption
for methodology.
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temperatures is likely due to different HbC concentrations
in the two cells.
Control experiments in which RBC from a control mouse
(C57, expressing exclusively mouse Hb single) were incu-
bated in 3% NaCl revealed no crystals. However, after 4 h, a
small number of these cells exhibit noncrystalline aggregate
forms that are not tethered to the membrane (not shown). If
the cells are exposed to isotonic saline, these aggregates
shrink in size and move about randomly until they are
completely dissolved. Large aggregates, about the diameter
of the mouse RBC (;6 m), are seen in some of the cells and
appear striated, suggestive of ﬁbrillar structure.
In summary, induced intraerythrocytic HbC L-L phase
separation and crystallization follow many of the thermo-
dynamics and kinetic characteristics of crystal growth pro-
cesses observed in vitro. However, the presence of the RBC
membrane induces speciﬁcity of the intracellular crystalli-
zation: the tethering of the crystal to the membrane likely
indicates a role of the membrane as a preferred center for
crystal nucleation, either directly or via the formation of an
amorphous aggregate. The phase behavior of HbC in the
RBC cytosol differs from the controls not only in its pro-
pensity to crystallize, but also in its ability to form dense
liquid phases. It should also be noted that, for in vitro solu-
tions of Hb (HbC and HbS), trace amounts of PEG appear to
be required for L-L phase separation (e.g., Chen et al. (13)
and Galkin et al. (19)). In this study of HbC RBC, no addi-
tives were employed other than the hypertonic solutions of
NaCl. The ﬁndings presented here, suggesting L-L phase
separation in the HbC RBC, support our earlier proposal that
the RBC may contain components that behave like PEG in
vitro to effect L-L phase separation (13). The identiﬁcation of
FIGURE 7 Equilibrium between intraerythrocytic HbC crystals and the
RBC cytosol. Imaging by temperature-controlled DIC microscopy. Crystals
were formed by incubation of RBC at 37C in 3% NaCl solution. The
incubating solution was completely replaced by 2.5% NaCl solution (ﬁnal
concentration). Temperature was lowered in steps from 37C to 30.6C;
select frames are shown. The accuracy of temperature control is 0.1C (see
Materials and Methods). Temperature was lowered to each subsequent step
after equilibrium between crystals and cytosol, as judged from the cessation
of dissolution obtained at the previous step. Crystals in different cells
dissolved completely at different temperatures, indicating different HbC
concentrations in the cells.
FIGURE 6 Reversibility of intraerythrocytic HbC crystal growth and
dissolution. Imaging by temperature-controlled DIC microscopy. Crystals
were formed by incubation of RBC at T¼ 37C in hypertonic NaCl solution.
The incubating solution was completely replaced by a 2.5% NaCl solution.
Temperature was slowly (over ;1 h) lowered to 35C. The respective
images of the cells are in the left column. The temperature was then raised to
the same 37C. The sequence of images in the right column is from bottom
to top. The accuracy of temperature control is 0.1C (see Materials and
Methods).
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these speciﬁc components will be the subject of a separate
investigation.
Overview of L-L phase separation and the
RBC membrane
Nucleation upon the erythrocyte membrane in the formation
of the liganded HbC crystal or deoxy HbS polymer now
becomes a possibility, especially in consideration of the
well-known speciﬁc interaction of Hb with the cytosolic
side of the RBCmembrane. In vitro studies demonstrate that
human Hb binds to cytosolic Band 3 (cB3H) of the eryth-
rocyte membrane with an afﬁnity dependent on the Hb
variant (HbC.HbA2.HbS.HbA) (33,34). We recently
showed that, in the oxygenated state, HbC and HbS are
bound with higher afﬁnity to the transgenic mouse RBC
membrane (32).
Crystallographic evidence shows that the cB3H 11 amino
acid N-terminus peptide binds to deoxy Hb central cavity
residues, including those that bind 2,3 diphosphoglycerate
(DPG) (46). However, it has also been established that oxy
Hb binds to the cytosolic portion of Band 3, albeit with a
lower afﬁnity that deoxy Hb. Whether oxy Hb dimers (in
contrast to tetrameric Hb) bind to Band 3 in the RBC remains
to be resolved. (See Salhany (47) for a recent overview of oxy
and deoxyHb binding to Band 3.) A recent report by Low and
colleagues (48) points to the N-terminus residues 12–23 as a
high-afﬁnity site for deoxy Hb, and thus introduces the
likelihood that the Hb-Band 3 narrative may be rewritten or
certainly further qualiﬁed. The complete function of Hb
binding to Band 3 (the transmembrane anion exchanger)
remains unknown, but evidence strongly suggests that Hb
binding to the cytosolic portion of Band 3 may play a sig-
niﬁcant role in regulating erythrocyte glycolysis, as well as
oxygen regulation of RBC properties (48–50). Band 3 is now
considered to function within a complex or metabolon, and
its interaction with Hb is now implicated in nitric oxide/nitrite
transport and physiology (48,51,52).
The high-afﬁnity binding of HbC and HbS to the human
RBC membrane with Band 3 implicated (33,34,53) and to
the mouse RBC (32) provides a basis for the hypothesis that
the membrane may serve as an intraerythrocytic site of
nucleation for the deoxygenated HbS polymer (54), and, as
suggested in this study, in the formation of the liganded
HbC crystal. The possibility that the complex RBC mem-
brane (as well as some RBC cytosolic components) plays a
role in HbC nucleation and crystallization was indicated
earlier by in vitro studies demonstrating that oxy HbC
crystallization is accelerated by the presence of the cytosolic
N-terminus domain of human Band 3 and the 11 amino acid
N-terminus Band 3 peptide (55). Oxy Hb binding to Band 3
may be explained by the following: oxy/liganded b6 mutant
Hbs exhibit an altered central cavity that may give rise
to their unique Hb intra- and intermolecular interactions
(55–59). Nevertheless, with the data presented in this study,
we cannot make any inference regarding the purported site
of binding.
In vitro studies of membrane effects on the nucleation of
deoxy HbS (recently summarized and readdressed by
Aprelev et al. (54)) showed an 80% enhancement of the
nucleation rate where deoxy HbS was immediately adjacent
to sickle cell membrane open ghosts. These observations for
HbS lend support to the study presented here, which shows
a propensity of the RBC membrane surface to exhibit both
noncrystalline forms and higher ordered forms of HbC.
Indeed, the dissolution of the intraerythrocytic crystal that
remains bound to the cell surface until it converts to a
noncrystalline form is suggestive of a membrane nucleation
site for the intraerythrocytic HbC crystal involving initia-
tion or wetting by a dense liquid droplet. The suggested
membrane nucleation site is indeed a complex issue, espe-
cially in light of new evidence that Hb has a greater afﬁnity
for residues 12–23 of the Band 3 N-terminus (48). In vitro
studies of mutants HbC and HbS in the presence of this
peptide will aid in illuminating the possibility of Band 3 as a
nucleation site for oxy/ligandedHbC crystallization or de-
oxy HbS polymerization.
HbC nucleation on microscopic aggregates of hemi-
chromes bound to the RBC membrane is an alternative
possibility that cannot be completely ruled out, since RBC
containing HbC exhibit hemichrome aggregates bound to
the membrane (34) and enhanced membrane fragility (23).
The notion that some HbC ‘‘precrystalline’’ structures and
the RBC membrane play a secondary role in generating RBC
rigidity, fragmentation, and microcytosis, as observed in
HbC hemoglobinopathy, has already been suggested in sys-
tematic studies of human HbC RBC by Charache et al. (23).
(A recent overview of HbC in the RBC can be found in
Brittain et al. (60).) The results presented here add to the role
of the RBC membrane in this hemoglobinopathy (e.g.,
alterations in potassium transport observed in both human
and mouse HbC RBC (61,62)), and suggest that the HbC
RBC membrane or its membrane abnormalities may serve
as a nucleation site for HbC crystallization. It is noteworthy
that the solubility properties and behavior of HbC within the
RBCmay seem to be in contrast to in vitro behavior observed
with hemolysates (23), but are accounted for by ‘‘unique
conditions of the RBC that have yet to be determined’’
(63). Elucidation of these unique conditions is under way
with the normal and pathologic human RBC and normal
C57/Bl mouse RBC proteomes recently described (e.g.,
64,65).
The involvement of the cell membrane in the nucleation of
higher-ordered proteins is a phenomenon reported in other
biosystems, such as in the aggregation of a-synuclein (66).
Furthermore, as some of us noted earlier (67), the implication
of intracellular L-L phase separation before higher-order
aggregation sets the stage for designing drug therapies for
various diseases correlated with protein aggregates, poly-
mers, or crystals.
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